Antigen receptor signaling coordinates the antibody response to infection or immunization, but the nature of the signals that guide the formation of high-affinity memory B cells and long-lived humoral immunity remains unclear. Two classes of antibody-deficiency syndromes are now recognized as arising from defects in antigen receptor signaling: defects in early B cell development and common variable immunodeficiency (CVID) 1 . Defects in early B cell development result from mutations in genes encoding the components of the B cell antigen receptor (BCR) and the Bruton's tyrosine kinase signaling cascade immediately downstream. These syndromes are readily identified by agammaglobulinemia and lower numbers of circulating B cells. In contrast, CVID syndromes have relatively normal B cell numbers and may have qualitative or quantitative defects in immunoglobulin production 2 . CVID is the most common clinically important primary immunodeficiency, yet over 75% of cases cannot be explained genetically or mechanistically at present 3 . A small number of cases result from mutations in the gene encoding CD19 (A000538) 4 , a coreceptor for enhancing BCR signaling that recruits phosphatidylinositol-3-OH kinase (PI(3)K; A001770) 5 . Other subsets are due to mutations in the gene encoding TACI, which is one of the receptors for the tumor necrosis factor-related cytokines BAFF and APRIL 6,7 , or mutations in the gene encoding ICOS, which serves as a costimulatory receptor for follicular helper T cells 8 . Understanding the variable antibody responses and deficiencies of switched memory B cells in the CVID spectrum of disorders 9 is hindered by the limited understanding of the genes and signaling mechanisms that are specifically required for the maturation and longevity of the antibody response.
Antigen receptor signaling coordinates the antibody response to infection or immunization, but the nature of the signals that guide the formation of high-affinity memory B cells and long-lived humoral immunity remains unclear. Two classes of antibody-deficiency syndromes are now recognized as arising from defects in antigen receptor signaling: defects in early B cell development and common variable immunodeficiency (CVID) 1 . Defects in early B cell development result from mutations in genes encoding the components of the B cell antigen receptor (BCR) and the Bruton's tyrosine kinase signaling cascade immediately downstream. These syndromes are readily identified by agammaglobulinemia and lower numbers of circulating B cells. In contrast, CVID syndromes have relatively normal B cell numbers and may have qualitative or quantitative defects in immunoglobulin production 2 . CVID is the most common clinically important primary immunodeficiency, yet over 75% of cases cannot be explained genetically or mechanistically at present 3 . A small number of cases result from mutations in the gene encoding CD19 (A000538) 4 , a coreceptor for enhancing BCR signaling that recruits phosphatidylinositol-3-OH kinase (PI(3)K; A001770) 5 . Other subsets are due to mutations in the gene encoding TACI, which is one of the receptors for the tumor necrosis factor-related cytokines BAFF and APRIL 6, 7 , or mutations in the gene encoding ICOS, which serves as a costimulatory receptor for follicular helper T cells 8 . Understanding the variable antibody responses and deficiencies of switched memory B cells in the CVID spectrum of disorders 9 is hindered by the limited understanding of the genes and signaling mechanisms that are specifically required for the maturation and longevity of the antibody response.
To identify additional genes and mechanisms that generate mature antibody responses, and animal models for understanding CVID and related immunodeficiencies, we describe here an immunization screen for selective defects in antibody-response maturation and longevity in mouse pedigrees segregating thousands of induced single-nucleotide substitutions. The first two pedigrees with humoral immune deficiency identified by this screen resulted from independent mutations in Dock8, which encodes a previously obscure member of the DOCK family of Rho-Rac guanine-exchange factors. The consequences of this mutation in B cells provide evidence that polarization of lymphocyte antigen receptors and integrins into an immunological synapse is critical for signaling survival and the establishment of high-affinity antibody-producing cells and long-lasting immunity, and yield a timely animal model for understanding human immunodeficiency.
RESULTS

Immunization screen
To understand the generation of long-lived humoral immunity, we developed a genetic screen that could identify mutant mice with a failure to mount long-lived, high-affinity antibody responses despite a relatively normal initial wave of antibody production. We tested 301 pedigrees of C57BL/6 mice, each segregating thousands of Nethyl-N-nitrosourea-induced single-nucleotide substitutions, for initial and mature serum antibody after immunizing multiple siblings of each pedigree with a mixture of antigens. Two recessive mutations that disrupted antibody response maturation ( Fig. 1) were propagated from independent pedigrees (called 'captain morgan' (cpm) and 'primurus' (pri) here). During the initial antibody response, immunoglobulin G (IgG) antibodies to killed Bordetella pertussis bacteria and to the protein antigen chicken γ-globulin (CGG) were correctly polarized to IgG2c and IgG1, respectively, and reached indistinguishable titers 14 d after immunization of pri/pri homozygous mice, cpm/cpm mice and their wild-type siblings (Fig. 1a , top, 1b and data not shown). As the majority of antibodies to CGG and B. pertussis produced at this time come from extrafollicular B cell clonal expansion and plasma cell formation acting together with T helper type 1 (T H 1) and T H 2 T cells in the T cell zone 10 , the absence of a substantial effect of the mutations on this phase of antibody production established that this phase of B cell and T cell activation was intact. The homozygous mutations also did not have an appreciable effect on T cell-independent (TI-2) extrafollicular B cell responses to nitrophenyl-hapten coupled to the polysaccharide antigen Ficoll (Fig. 1a) . However, during the mature phase of the antibody response, either after a booster immunization (44 d; Fig. 1a ) or without boosting (28 or 56 d after primary immunization; Fig. 1b) , IgG antibody to CGG failed to be sustained in pri/pri or cpm/cpm mice or in compound-heterozygous mice. The CGG immunogen carried a haptenic chemical group, azobenzenearsonate (ARS), which elicited appreciable antibody only in wild-type mice after 4 weeks (Fig. 1b) due to the need for antibody hypermutation and affinity maturation 11, 12 . Antibody to the ARS hapten failed to develop in pri-or cpm-homozygous mice or compound-heterozygous mice. A comprehensive analysis of B cell subsets in blood and primary and secondary lymphoid organs showed qualitatively normal development of circulating mature subsets but a near absence of marginal zone B (MZB) cells (Fig. 2) . The formation of immature B cells in the bone marrow and accumulation of mature follicular B cells seemed normal in mutant mice (Fig. 2a,b and data not shown), but there was profound deficiency of splenic MZB cells in cpm-and pri-homozygous mice and cpm/pri compound-heterozygous mice ( Fig. 2a-d and Supplementary Fig. 1 ), which was cell autonomous to B cells bearing the mutation in mixed chimeras (Fig. 2e) . MZB cell numbers were much higher in transgenic mice overexpressing the cytokine BAFF, but this failed to restore MZB cell formation by mutant cells (Supplementary Fig. 2 ). The frequency of B-1 cells in the peritoneal cavity was 60% lower in the mutant mice (Fig. 2f) , and this was cell autonomous in mixed chimeras. Analysis of splenic T cells showed normal numbers of activated or memory CD4 + and CD8 + T cells but a mean 50% lower number of naive T cells in cpm-and pri-homozygous mice and in cpm/pri compound-heterozygous mice, although this trait overlapped the lower end of the normal range and was not reliable for identifying individual homozygous mice (Fig. 2g) . In 50:50 bone marrow chimeras with mutant T cells reconstituting in the presence of wild-type T cells, T cells bearing the mutation had a cell-autonomous competitive disadvantage and comprised only 5% of the total peripheral T cells (Fig. 2h) .
Dock8 mutations
MZB cell deficiency provided a clear mendelian recessive trait to map and identify the causative cpm and pri mutations. Both mutations mapped to the same region of chromosome 19 ( Supplementary  Fig. 3 ), and sequencing of B cell-expressed transcripts in the minimal 4.5-megabase interval identified independent mutations in Dock8 (Fig. 3a) . DOCK8 is a little studied member of a family of proteins that are critical activators of the Rho family of small GTPases (G proteins) in worms, flies and mammals 13 . In other DOCK proteins, the DOCK-homology region 1 (DHR1) domain (also known as the CDM-zizimin homology 1 (CZH1) domain) binds phosphatidylinositol-3,4,5-triphosphate (PtdIns(3,4,5)P 3 ) lipids generated by PI(3)K activity to promote localized membrane binding and activation. The DHR2 (CZH2) domain binds to Rho-family G proteins (Rho (A002062), Rac and Cdc42), promoting GTP exchange and activating local cytoskeletal changes, integrin-mediated adhesion, lamellipodia formation, cell polarization, phagocytosis or cell fusion 13, 14 . DOCK8 has been isolated in a yeast two-hybrid screen for binding partners of Cdc42 and has been found to localize at lamellipodia in fibroblasts 15 , but its in vivo function has remained unknown.
The cpm mutation was a T-to-C substitution in the exon-20 splicedonor sequence that caused aberrant mRNA splicing between cryptic 5′ or 3′ splice donors and the normal exon 21 splice acceptor (Fig. 3b,c) . Sequencing of 74 cDNA clones from cpm/cpm splenocytes showed aberrant splicing to yield frameshifts and premature stop codons that eliminate the DHR2 domain entirely (Fig. 3c) . The pri mutation, in exon 43, was a T-to-C substitution that changed codon 1827 from a serine residue to a proline residue (Fig. 3a) . The mutant serine residue was absolutely conserved in vertebrate DOCK8 and in the DHR2 domain of DOCK6, DOCK7 and DOCK9 (Fig. 3d) . In the structure of DOCK9 in complex with Cdc42 (ref. 16 ), this conserved serine lies in DHR2 lobe B α-helix 6, which forms part of the Cdc42-binding site and provides four Cdc42 contact residues (Fig. 3d) . The pri substitution of Ser1827 to Pro1827 would be expected to break this α-helical structure and interfere with the guanine-exchange factor activity of the DHR2 domain. The nature of the mutations, their recessive inheritance and their failure to complement in crosses established the cause of the antibody response, B cell and T cell defects as being due to loss of normal DOCK8 function. Dock8 mRNA was expressed ten times more abundantly in B lymphocytes and T lymphocytes than in other cells ( Supplementary  Fig. 4 ). As mice homozygous for the truncating Dock8 cpm allele are weaned at normal frequency and seem normal in growth and behavior, we conclude that DOCK8 has a relatively specialized role in adaptive immunity.
Crippled germinal centers
As immunization of DOCK8-mutant mice elicited a normal early wave of antibody formation but the response failed to mature or be sustained, we sought to define the cellular basis for this variable immune deficiency. After immunization with sheep red blood cells (SRBCs), wild-type mice formed large germinal centers (GCs), indicated by peanut agglutinin-positive (PNA + ) IgD -B cells, whereas pri/pri and cpm/cpm mice formed only small PNA + clusters ( Fig. 4a and data not shown). Phenotypically normal CD95 + GL7 + B220 + GC B cells were readily detected by flow cytometry in homozygous mutants after immunization, but their numbers were only 15% of normal (Fig. 4b) . Immunization of competitive hematopoietic chimeras, A r t i c l e s constructed by reconstitution of irradiated mice with a mixture of CD45.1 + wild-type and CD45.2 + pri/pri or cpm/cpm bone marrow, showed that B cells bearing the Dock8 mutation contributed normally to the main subsets of B220 + and IgD + recirculating follicular B cells but contributed poorly to the B220 + CD95 + GL7 + GC subset, particularly at day 11 after immunization, when the response has begun maturing (Fig. 4c) . The mutations therefore acted autonomously in individual B cells to interfere selectively with their capacity to differentiate into or sustain a GC state.
We determined the precise step at which the mutation interfered with GC B cells by monitoring a homogeneous population of B cells specific for hen egg lysozyme (HEL) antigen after adoptive transfer into wild-type mice immunized with SRBCs conjugated to HEL (Figs. 5 and 6) . We crossed mice with the pri mutation with CD45.1 SW HEL -transgenic mice, which bear a rearranged HEL-specific variable-diversity-joining heavy-chain (V(D)J H ) element targeted to the Igh locus (which encodes the immunoglobulin heavy chain) combined with a HEL-specific κ-light-chain transgene 17 [18] [19] [20] . Six amino acids in the complementarity-determining region 2 (CDR2) loop of the SW HEL V H chain contact native HEL at Asp101 (ref. 21) , and selection of amino acid replacements in these CDR2 residues increases the affinity for D101R-substituted HEL 2X or HEL 3X antigens in SW HEL GC cells (ref. 19 and unpublished data).
In wild-type recipients immunized with HEL 2X SRBCs, both wildtype and pri/pri HEL-specific B cells underwent similar differentiation into GL7 + Fas + cells scattered in follicles 2.5 d after immunization, and similar rates of isotype switching to IgG1 occurred between days 3.5 and 4.5 ( Fig. 5 and Supplementary Fig. 5 ). GCs formed in follicles on day 4.5, when the majority of both wild-type and mutant SW HEL B cells had differentiated into Fas hi GL7 hi GC cells. No accumulation or GC differentiation by donor B cells occurred in recipients immunized with SRBCs lacking the HEL 2X antigen. Immunoglobulin class switching is a sensitive indicator of helper T cell signals 22 and requires CD40 on SW HEL B cells in immune responses to HEL 2X SRBCs 23 . These data reinforce those presented above (Fig. 1) in indicating that DOCK8 is not essential for the initial phase of B cell activation and functioning together with helper T cells in vivo. In contrast, DOCK8 deficiency more profoundly disrupted the response 4.5-10 d after immunization, when wild-type SW HEL B cells undergo hypermutation and affinity maturation. Although there was no discernable difference in their location in GCs on days 4.5 and 5 after immunization (Fig. 6a and Supplementary Fig. 5 ), the accumulation of SW HEL pri/pri GC cells was one third that of wild-type control cells at this time (Figs. 5b and 6b ) and fell to one fortieth that of controls by day 9 despite ongoing GCs composed of wild-type host B cells and T cells (Fig. 6b) . We also observed this difference after adoptive transfer of lymph node cells from SW HEL mice (Supplementary Fig. 6 ), which excluded the possibility that it resulted from the absence of MZB cells among transferred pri/pri SW HEL spleen cells. IgG1-switched B cells doubled as a percentage of wild-type SW HEL B cells on day 9 compared with the percentage at day 7 or 5, whereas the percentage IgG1 + failed to increase in SW HEL GC B cells bearing the pri mutation (Fig. 6b) .
Nine days after immunization with HEL 2X SRBCs, sequencing of Igh in individual flow cytometry-sorted SW HEL GC B cells showed that wild-type cells had accumulated a high ratio of replacement to silent mutations (10.3) in sequences encoding the CDR2 residues contacting the D101R substitution in HEL 2X (Fig. 6c,d and Supplementary Fig. 7) . Six of the thirty-eight cells analyzed (16%) had Y58F replacements in CDR2 that have been shown to increase affinity 24 . Flow cytometry staining with nanomolar concentrations of the HEL 3X antigen allowed us to directly count high-affinity IgG + variants for D101R-substituted HEL at this time, which comprised 18% of wild-type IgG + SW HEL B cells, 3.4% of all SW HEL B cells and 0.0082% of all spleen cells (Fig. 6e) . Sorted pri/pri GC cells on day 9 had accumulated the same or a greater load of V H nucleotide mutations (a mean of 2.3 per cell) compared with that of their wild-type counterparts (a mean of 2.0), including similar numbers of mutations in the CDR2 codons. Despite undergoing comparable hypermutation, the mutant GC cells had a low ratio of replacement to silent mutations in CDR2 (2.4), and only 2 of 44 cells (4.5%) had Y58F replacements ( Fig. 6d and  Supplementary Fig. 7) . Flow cytometry staining with HEL 3X showed that pri/pri SW HEL B cells generated few high-affinity IgG + variants to D101R-substituted HEL even after adjustment for their poor survival (Fig. 6e) . These cells represented only 3% of IgG1 + SW HEL B cells, 0.2% of the SW HEL B cells and 0.00004% of all spleen cells. DOCK8 deficiency thus allows normal immunoglobulin gene hypermutation but diminishes survival and selection so that the formation of higheraffinity IgG + B cells was only 0.5% of normal. A r t i c l e s the integrin LFA-1 to bind strongly to its ligand ICAM-1 (A002871) on the antigen-presenting membrane, which promotes strong B cell adhesion and spreading 25 . During the first 3 min of this process, BCRs become polarized in the center of the adhesion zone and cluster antigen into a central supramolecular cluster. LFA-1 becomes polarized into a surrounding peripheral supramolecular cluster, where it concentrates ICAM-1 in the antigen-presenting membrane. We isolated DOCK8-mutant and wild-type B cells from MD4-transgenic mice expressing HEL-specific BCRs. We allowed the B cells to settle on planar membranes containing fluorescence-tagged HEL antigen and ICAM-1 and imaged them by a combination of confocal, differential interference contrast and interference-reflection microscopy. Both mutant and wild-type cells adhered and clustered antigen into a central supramolecular cluster, but the mutant cells showed an inability to cluster ICAM-1 into a peripheral supramolecular cluster and consequently formed smaller areas of close membrane apposition (Fig. 7a) .
Defective B cell synapses
In contrast to its effect on the disruption of B cell synapse formation, Dock8 mutation had no effect on other BCR signaling events, including an increase in intracellular calcium stimulated by antibody to IgM (antiIgM; Fig. 7b) or phosphorylation of the kinase Erk (data not shown), induction of the activation markers CD25, CD86 and CD69 (Fig. 7c and data not shown), or induction of DNA synthesis (Supplementary Fig. 8 ) or cell division (Fig. 7d) , even in conditions of limiting BCR engagement ( Fig. 7d and Supplementary Figs. 9 and 10 ). The mutation also had no discernable effect on CD40-or lipopolysaccharide-stimulated activation or proliferation (Fig. 7d, Supplementary Figs. 8-10 and data not shown). DOCK8-mutant B cells were also normal in forming stable conjugates during antigen presentation to specific CD4 + T cells, in a B cell-T cell adhesion process that depends on the adaptor protein SAP in T cells and is important for GC formation 26 ( Supplementary Fig. 11 ). Dock8 mutation also did not decrease the in vivo homing and accumulation of B cells in lymph nodes in mixed chimeras (Supplementary Fig. 12 ), despite the dependency of this process on CCR7 and CXCR4 chemokine receptor signaling of the adhesion of LFA-1 to ICAM-1 (ref. 27). After adoptive transfer, DOCK8-mutant SW HEL B cells migrated and positioned themselves normally in follicles and GCs ( Fig. 6a and Supplementary Fig. 5 ). Mutant and wildtype spleen B cells were indistinguishable by in vitro chemotaxis to the three main chemotactic factors for B cells: S1P, CXCL12 and CXCL13 (Supplementary Fig. 13 ). DOCK8 therefore functions quite specifically in B cells, being necessary for BCR signaling of integrin-ICAM-1 polarization in the immunological synapse but not for many other BCR-mediated, chemotactic or integrin-mediated processes.
DISCUSSION
The findings presented here have shown that mutations in Dock8 caused humoral immunodeficiency that preserved T cell-independent antibody formation and the initial extrafollicular wave of T celldependent antibody formation but severely crippled the longevity and affinity maturation of T cell-dependent antibody responses. The basis for these humoral deficits was a profound defect in the survival and selection of GC B cells during the affinity-maturation phase of GC responses, due to an intrinsic requirement for DOCK8 in the GC B cells themselves. The GC B cell defect may have been compounded by the lower number of CD4 + helper T cells in DOCK8-mutant mice, although mixed-chimera and adoptive-transfer studies clearly established that the mutation profoundly crippled the persistence and affinity maturation of mutant GC B cells even in the presence of a normal complement of helper T cells. In B cells, DOCK8 has a critical role in antigen recognition, being essential for the recruitment of ICAM-1 to the immunological synapse but unnecessary for the central events in BCR signaling to soluble ligands that lead to activation and proliferation. The requirement for DOCK8 in B cell synapse formation and for longevity and affinity maturation of T cell-dependent antibody elucidates an important step in the establishment of humoral immunity. The requirement for DOCK8 in the organization of a normally polarized B cell immunological synapse is very similar to defects in B cell formation of peripheral supramolecular clusters caused by mutations in the genes encoding the Rho-family G protein Rac2 (A002002) or the Rac guanine-exchange factors Vav1 and Vav2 (A002361) 28 . Compared with those proteins, DOCK8 seems to have a more restricted function for BCR-integrin coordination, because follicular B cell development, migration, chemotaxis, activation and T cell-independent type 2 antibody responses were normal in DOCK8-mutant B cells, whereas pleiotropic defects in these processes are caused by mutations in genes encoding Rac2 or Vav proteins. In addition to their role in BCR-integrin coordination, Rac2 and Vav proteins are critical for the initial events in BCR signaling of intracellular calcium and proliferation in response to soluble anti-IgM and for chemokine responsiveness [29] [30] [31] [32] . The specificity of DOCK8 function in BCR-integrin signaling and GC selection in B cells also contrasts with that of DOCK2, whose gene mutation in mice causes profound lymphopenia, disrupted lymphoid architecture, crippled B cell migration to lymph nodes and to CXCL12 and CXCL13 chemokines in vitro 33 and a generalized defect in B cell integrin activation in response to a range of stimuli 34 . To understand how DOCK8 serves such a restricted role in B cells compared with that of Rac2, Vav or A r t i c l e s DOCK2, it will be worthwhile in future work to define the G proteins and biochemical pathway regulated by DOCK8 for the formation of B cell immunological synapses. Mutations in CD19, which encodes a coreceptor that is phosphorylated by BCR engagement and then recruits PI(3)K 5 , cause a human CVID syndrome with normal numbers of IgD + recirculating B cells and presence of GCs but low numbers of CD27 + memory B cells and low-avidity antibody to rabies vaccine 4 . In the mouse, Cd19 mutations that eliminate the protein or inactivate its ability to recruit PI(3)K cause a humoral immunodeficiency syndrome that closely resembles that caused by Dock8 mutation. These mice have normal numbers of recirculating IgD + B cells, lack of MZB cells, a normal calcium response and proliferation in response to stimulation with soluble anti-IgM, relatively normal TI-2 antibody responses, and initiation of GC reactions and isotype switching but limited expansion of GCs and failure of affinity maturation or long-lived antibody [35] [36] [37] [38] . The smaller GC size and loss of MZB cells in CD19 mutant mice can be 'rescued' by a mutation in Pten (encoding PtdIns(3,4,5)P 3 phosphatase), which emphasizes the involvement of PtdIns(3,4,5)P 3 lipid products of PI(3)K in these processes 39 . A distinction between mutations in the genes encoding CD19 and DOCK8 is that CD19 deficiency greatly diminished the early step of B cell adhesion and clustering of membrane HEL antigen in the bilayer assay used here 40 , whereas DOCK8 deficiency was restricted to disruption of the later step of peripheral supramolecular cluster formation. This difference may reflect the proximal role of CD19 in recruiting not only PI(3)K but also BCR signaling molecules with general involvement in the initiation of BCR signaling, such as Lyn 41 . The phenotypic similarities and the fact that the DHR1 domain of related DOCK proteins binds PtdIns(3,4,5)P 3 lipids to recruit these guanine-exchange factors to the membrane and activate Rac at sites of PI(3)K activation 13 make it logical to hypothesize that DOCK8 serves as an effector downstream of CD19 and PI(3)K to promote G protein signaling events critical for integrin polarization at the synapse and for the survival of MZB cells and GC B cells.
The discovery here that Dock8 mutations resulted in humoral immune deficiency in mice is complemented by the independent discovery of DOCK8 mutations associated with immunodeficiency in humans 42 . Recurrent sinopulmonary bacterial infections typical of humoral immunodeficiency have been observed in DOCK8-deficient people, in addition to cutaneous viral infections usually associated with partial T cell deficiency. Despite having normal or increased concentrations of serum IgG, these people show a variable lack of antibody to T cell-dependent vaccines. Our data here have established that DOCK8 deficiency indeed causes a primary humoral immunodeficiency that selectively affects the longevity and maturation of T cell-dependent antibody responses to protein antigens and have established its cellular basis and its B cell-intrinsic role. Although the focus of our study here was to understand the humoral defects caused by DOCK8 deficiency, an additional requirement for DOCK8 in T cells has been demonstrated here and associated with the human syndrome. Future, separate studies will be needed to define the cellular basis for the lower numbers of peripheral T cells caused by Dock8 mutation.
The requirement for DOCK8 in the formation of MZB cells may be explained by the fact that this B cell subset is highly dependent on both BCR-CD19-PI(3)K signaling 35, 38, [43] [44] [45] and integrin signaling 46, 47 . Coordinated signaling by BCR and integrins has also been proposed as being critical for GC B cell survival and selection, as ICAM-1 has high expression on follicular dendritic cells (FDCs) presenting antigen in GCs and inhibits apoptosis of GC B cells in vitro 48 . ICAM-1 is not induced on FDCs when the gene encoding the kinase IKKβ is selectively inactivated in these cells, and this leads to small GCs 49 . In vivo soluble antigen has the opposite effect from FDC-bound antigen on GC B cells by triggering apoptosis within 4 h (refs. 50, 51) . Costimulation with ICAM-1 has also been shown to modify the outcome of TCR stimulation in ways that are distinct from costimulation with CD28, converting a death signal into a survival signal in immature thymocytes 52, 53 and being critical in formation of memory CD8 + T cells 54 . We speculate that DOCK8 immunodeficiency may result from the failure of GC B lymphocytes and some classes of T cells to organize a normal immunological synapse and thereby receive an integrin costimulus during antigen recognition that is needed to convert an antigen receptor-induced death signal into a survival signal.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
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